Summary
TASER International, Inc. (AXON) demonstrated robust top-line growth in the second quarter of 2015, with net sales increasing by 25.7% year-over-year to $46.7 million. This growth was driven by strong performance in both the TASER Weapons segment (+15.8%) and a significant surge in the Axon segment (+97.5%), indicating successful market adoption of their integrated hardware and software solutions for law enforcement. The company also showed improved profitability, with gross margin increasing to 65.8% and net income rising by 57.1% to $6.1 million. This was achieved despite an increase in R&D spending, particularly in the Axon segment, reflecting the company's investment in future growth. Management highlighted increased adoption of the TASER X26P and X2 smart weapons, alongside continued strong demand for Axon on-officer cameras and the Evidence.com platform as key drivers for the quarter's financial performance.
Financial Highlights
50 data points| Revenue | $46.71M |
| Cost of Revenue | $15.99M |
| Gross Profit | $30.72M |
| R&D Expenses | $5.91M |
| SG&A Expenses | $15.44M |
| Operating Expenses | $21.35M |
| Operating Income | $9.37M |
| Net Income | $6.10M |
| EPS (Basic) | $0.11 |
| EPS (Diluted) | $0.11 |
| Shares Outstanding (Basic) | 53.64M |
| Shares Outstanding (Diluted) | 54.80M |
Key Highlights
- 1Net sales increased by 25.7% year-over-year to $46.7 million, driven by strong performance across both segments.
- 2The Axon segment experienced exceptional growth, with net sales up 97.5% to $8.9 million, highlighting the increasing adoption of their technology solutions.
- 3Gross margin improved significantly to 65.8% from 62.4% in the prior year's quarter, reflecting improved operational efficiency and product mix.
- 4Net income grew by 57.1% to $6.1 million, with diluted EPS rising to $0.11 from $0.07.
- 5Research and Development expenses increased by 70.9% to $5.9 million, with a substantial portion allocated to the Axon segment's new product development.
- 6Bookings for Axon products and services showed substantial growth, increasing 170.0% to $30.6 million, indicating a strong future revenue pipeline.
- 7The company maintains a healthy balance sheet with $40.4 million in cash and cash equivalents and $46.3 million in short-term investments, and has $7.0 million available under its revolving credit facility.